Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis

Clinical trial NCT03781310 · UNKNOWN

Trial details

NCT number: NCT03781310
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis Tocilizumab

Start date: 2018-12-01
Primary completion: 2019-06-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.